MAPK14 and chronic kidney disease: 96 also attributed their anti-fibrotic effects in CKD to the inactivation of the reactive oxygen species (ROS)—mediated p38 mitogen-activated protein kinases/extracellular signal-regulated kinase (MAPK/ERK) pathway.